Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at MEDI4736, savolitinib and tremelimumab for advanced kidney cancer (CALYPSO)

Overview

Cancer types:

Kidney cancer, Renal cell cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is for people with a type of kidney cancer called renal cell cancer that has grown outside the kidney or spread to another part of the body.

Recruitment start: 5 January 2017

Recruitment end: 10 March 2021

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Thomas Powles

Supported by

Astra Zeneca

Queen Mary University of London

Last reviewed: 30 March 2021

CRUK internal database number: 14557

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.